Trials / Conditions / Recurrent Dedifferentiated Liposarcoma
Recurrent Dedifferentiated Liposarcoma
3 registered clinical trials studyying Recurrent Dedifferentiated Liposarcoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma NCT05886634 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Active Not Recruiting | Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma NCT04668300 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable NCT03307616 | M.D. Anderson Cancer Center | Phase 2 |